Welcome to the first edition of our new series, Behind the Pick, where every stock recommendation becomes a lesson in disciplined investing. This isn’t just about what to buy—it’s about how to think.
Quick Snapshot
Metric
Value
Ticker
LLY
Sector
Healthcare
Market Cap
$621B
Valuation
Forward P/E: ~23
Risk Rating
Moderate
Behavioral Flag
Loss Aversion
This pick isn’t about chasing highs. It’s about understanding conviction when the crowd pulls back.
Why It’s on the Radar
- Shares fell ~27% after disappointing trial results for its oral weight-loss drug.
- Despite the drop, insiders—including the CEO and CFO—bought over $4M in shares.
- Analysts still forecast a 31% upside from current levels.
- Eli Lilly’s pipeline in diabetes, oncology, and immunology remains robust.
The Principle at Play
Lesson: Buying into quality during temporary dislocation
- Fundamentals remain strong—this is a sentiment-driven dip.
- A classic case of separating signal from noise.
- Teaches investors to look past headlines and assess long-term value.
Behavioral Finance Angle
Bias Watch: Loss Aversion
- Investors often overreact to bad news after a strong run-up.
- Insider buying signals rational confidence, not emotional panic.
- Ask yourself: Are you avoiding this stock because of fear, or because of facts?
Portfolio Fit
This is a high conviction hold, not a speculative trade.
- Ideal for a core healthcare allocation with growth tilt.
- Balances well against cyclical or tech-heavy exposure.
- Consider a 2–4% allocation with a 12–18-month horizon.
Zen Score™
Category
Score (1-10; 10 is best)
Valuation Discipline
6
Risk Management
8
Behavioral Alignment
9
Portfolio Fit
8
Zen Score helps investors stay grounded—especially when the market isn’t. The average Zen Score for LLY is 7.75, which is above the acceptable level of 7.5.
Takeaway
Behind every pick is a principle. Behind every principle is a path to mastery.
Eli Lilly reminds us that price isn’t the only signal. Insider conviction, pipeline strength, and behavioral discipline matter more than headlines.
Appendix
The Zen Score is a proprietary framework you can use to evaluate stock picks through the lens of disciplined investing. It’s designed to shift the focus from what’s hot to what’s wise—giving readers a structured way to assess not just potential returns, but alignment with long-term principles.
Zen Score Components (1–10 scale per category)
- Valuation Discipline: Is the stock reasonably priced relative to its fundamentals like EPS Growth estimates and forward PEG?
- Risk Management: How well does the pick fit within a diversified, risk-aware portfolio?
- Behavioral Alignment: Does the pick challenge common investor biases or reinforce sound psychology?
- Portfolio Fit: Is the stock suitable for a strategic allocation, or is it a speculative outlier?
Each pick gets a score in these four areas, creating a composite view that helps readers think beyond price charts and hype. It’s not a prediction tool—it’s a reflection tool.